Skip to main content
SpringerLink
Log in

Continuous Glucose Monitoring in the Hospital Setting: Current Status and Future Directions

  • Chapter
  • First Online:
Diabetes Management in Hospitalized Patients

Part of the book series: Contemporary Endocrinology ((COE))

  • 266 Accesses

Abstract

Investigation into the use of continuous glucose monitoring (CGM) in the hospital has rapidly progressed over the past several years. Advances in CGM technology and the need for glucose monitoring with remote viewing capabilities during the COVID-19 pandemic cultivated a new age of inpatient CGM investigation, highlighting the potential for outpatient CGM devices to transition into systems for inpatient care. Current data suggests that overall CGM is reliable, safe, and effective in the hospital setting, providing more comprehensive glucose data and the ability to alert healthcare providers to impending glycemic excursions. Currently, the United States Food and Drug Administration has not approved CGM for inpatient use, though there is some guidance from professional societies regarding continuation of personal CGM for patients during hospital admission. However, there is a need for ongoing research to define optimal use strategies for management of hospitalized patients using CGM and to further understand implementation needs and potential limitations in this setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Maiorino MI, Signoriello S, Maio A, Chiodini P, Bellastella G, Scappaticcio L, et al. Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146–56.

    Article  CAS  PubMed  Google Scholar 

  2. Pease A, Lo C, Earnest A, Kiriakova V, Liew D, Zoungas S. Time in range for multiple technologies in type 1 diabetes: a systematic review and network meta-analysis. Diabetes Care. 2020;43(8):1967–75.

    Article  PubMed  Google Scholar 

  3. Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: a review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med. 2021;38(5):e14528.

    Article  CAS  PubMed  Google Scholar 

  4. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 7. Diabetes technology: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S111–S27.

    Article  PubMed  Google Scholar 

  5. Davis GM, Faulds E, Walker T, Vigliotti D, Rabinovich M, Hester J, et al. Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: proof of concept. Diabetes Care. 2021;44(4):1055–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, et al. Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol. 2020;14(4):822–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gujral UP, Johnson L, Nielsen J, Vellanki P, Haw JS, Davis GM, et al. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Res Care. 2020;8(1):e001520.

    Article  PubMed  Google Scholar 

  8. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. Lancet Diabetes Endocrinol. 2021;9(3):174–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Agarwal S, Mathew J, Davis GM, Shephardson A, Levine A, Louard R, et al. Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care. 2021;44(3):847–9.

    Article  CAS  PubMed  Google Scholar 

  10. Davis GM, Galindo RJ, Migdal AL, Umpierrez GE. Diabetes technology in the inpatient setting for management of hyperglycemia. Endocrinol Metab Clin N Am. 2020;49(1):79–93.

    Article  Google Scholar 

  11. Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593–603.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Davis GM, Spanakis EK, Migdal AL, Singh LG, Albury B, Urrutia MA, et al. Accuracy of Dexcom G6 continuous glucose monitoring in non-critically ill hospitalized patients with diabetes. Diabetes Care. 2021;44(7):1641–6.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Migdal AL, Spanakis EK, Galindo RJ, Davis G, Singh LG, Satyarengga M, et al. Accuracy and precision of continuous glucose monitoring in hospitalized patients undergoing radiology procedures. J Diabetes Sci Technol. 2020;14(6):1135–6.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Perez-Guzman MC, Shang T, Zhang JY, Jornsay D, Klonoff DC. Continuous glucose monitoring in the hospital. Endocrinol Metab. 2021;36(2):240–55.

    Article  CAS  Google Scholar 

  15. Nair BG, Dellinger EP, Flum DR, Rooke GA, Hirsch IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care. 2020;43(11):e168–e9.

    Article  PubMed  Google Scholar 

  16. Tripyla A, Herzig D, Joachim D, Nakas CT, Amiet F, Andreou A, et al. Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes Metab. 2020;22(9):1678–82.

    Article  CAS  PubMed  Google Scholar 

  17. Singh LG, Levitt DL, Satyarengga M, Pinault L, Zhan M, Sorkin JD, et al. Continuous glucose monitoring in general wards for prevention of hypoglycemia: results from the glucose telemetry system pilot study. J Diabetes Sci Technol. 2020;14(4):783–90.

    Article  PubMed  Google Scholar 

  18. Fortmann AL, Spierling Bagsic SR, Talavera L, Garcia IM, Sandoval H, Hottinger A, et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabetes Care. 2020;43(11):2873–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, et al. Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial. Diabetes Care. 2022;45(10):2369–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Klarskov CK, Windum NA, Olsen MT, Dungu AM, Jensen AK, Lindegaard B, et al. Telemetric continuous glucose monitoring during the COVID-19 pandemic in isolated hospitalized patients in Denmark: a randomized controlled exploratory trial. Diabetes Technol Ther. 2022;24(2):102–12.

    Article  CAS  PubMed  Google Scholar 

  21. Dillmann C, Amoura L, Fall Mostaine F, Coste A, Bounyar L, Kessler L. Feasibility of real-time continuous glucose monitoring telemetry system in an inpatient diabetes unit: a pilot study. J Diabetes Sci Technol. 2022;16(4):955–61.

    Article  CAS  PubMed  Google Scholar 

  22. Holzinger U, Warszawska J, Kitzberger R, Herkner H, Metnitz PG, Madl C. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring. Intensive Care Med. 2009;35(8):1383–9.

    Article  CAS  PubMed  Google Scholar 

  23. Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014;18(4):453.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Leelarathna L, English SW, Thabit H, Caldwell K, Allen JM, Kumareswaran K, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations. Diabetes Technol Ther. 2014;16(2):97–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Siegelaar SE, Barwari T, Hermanides J, van der Voort PH, Hoekstra JB, DeVries JH. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit. J Thorac Cardiovasc Surg. 2013;146(5):1283–9.

    Article  CAS  PubMed  Google Scholar 

  26. Tingsarat W, Buranasupkajorn P, Khovidhunkit W, Boonchaya-Anant P, Laichuthai N. The accuracy of continuous glucose monitoring in the medical intensive care unit. J Diabetes Sci Technol. 2022;16(6):1550–4.

    Article  PubMed  Google Scholar 

  27. Faulds ER, Boutsicaris A, Sumner L, Jones L, McNett M, Smetana KS, et al. Use of continuous glucose monitor in critically ill COVID-19 patients requiring insulin infusion: an observational study. J Clin Endocrinol Metab. 2021;106(10):e4007–e16.

    Article  PubMed  Google Scholar 

  28. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 16. Diabetes care in the hospital: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S267–S78.

    Article  PubMed  Google Scholar 

  29. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

    Article  CAS  PubMed  Google Scholar 

  30. Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: the use of advanced technology in the management of persons with diabetes mellitus. Endocr Pract. 2021;27(6):505–37.

    Article  PubMed  Google Scholar 

  31. Galindo RJ, Umpierrez GE, Rushakoff RJ, Basu A, Lohnes S, Nichols JH, et al. Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol. 2020;14(6):1035–64.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Faulds ER, Jones L, McNett M, Smetana KS, May CC, Sumner L, et al. Facilitators and barriers to nursing implementation of continuous glucose monitoring (CGM) in critically ill patients with COVID-19. Endocr Pract. 2021;27(4):354–61.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Moon SJ, Jung I, Park CY. Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence. Diabetes Metab J. 2021;45(6):813–39.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Boughton CK, Tripyla A, Hartnell S, Daly A, Herzig D, Wilinska ME, et al. Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med. 2021;27(8):1471–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Breton MD, Kovatchev BP. One year real-world use of the control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther. 2021;23(9):601–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Davis GM, Peters AL, Bode BW, Carlson AL, Dumais B, Vienneau TE, et al. Safety and efficacy of the Omnipod 5 automated insulin delivery system in adults with type 2 diabetes: from injections to hybrid closed-loop therapy. Diabetes Care. 2023;46:742.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Emory University, Atlanta, GA, USA

    Georgia M. Davis

  2. Department of Medicine, Baylor College of Medicine, Houston, TX, USA

    Madhuri M. Vasudevan

Authors
  1. Georgia M. Davis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madhuri M. Vasudevan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Georgia M. Davis .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA

    Rifka C. Schulman-Rosenbaum

Ethics declarations

GMD is supported by the National Institutes of Health (NIH) under Award Number K23DK122199 and has received research support from Insulet Corp. and consulting fees from Medscape, Inc.

MV has no disclosures.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Davis, G.M., Vasudevan, M.M. (2023). Continuous Glucose Monitoring in the Hospital Setting: Current Status and Future Directions. In: Schulman-Rosenbaum, R.C. (eds) Diabetes Management in Hospitalized Patients. Contemporary Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-44648-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-44648-1_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-44647-4

  • Online ISBN: 978-3-031-44648-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation